Leukemia inhibitory factor promotes nasopharyngeal carcinoma progression and radioresistance - Liu, Shu-Chen; Tsang, Ngan-Ming; Chiang, Wen-Che; Chang, Kai-Ping; Hsueh, Chuen; Liang, Ying; Juang, Jyh-Lyh; Chow, Kai-Ping N.; Chang, Yu-Sun (The Journal of clinical investigation, 2013)
Keywords: Animals; Apoptosis; Biomedical research; Carcinoma - blood; Carcinoma - pathology; Carcinoma - radiotherapy; Cytokines; Deoxyribonucleic acid; Development and progression; Disease Progression; DNA; DNA Damage; DNA repair; Gamma Rays; Gene Expression Regulation, Viral; Heterografts; Humans; Leukemia; Leukemia Inhibitory Factor - antagonists & inhibitors; Leukemia Inhibitory Factor - blood; Leukemia Inhibitory Factor - physiology; Mechanistic Target of Rapamycin Complex 1; Medical prognosis; Mice; Mice, Inbred NOD; Mice, SCID; Multiprotein Complexes - physiology; Nasopharyngeal cancer; Nasopharyngeal Neoplasms - blood; Nasopharyngeal Neoplasms - pathology; Nasopharyngeal Neoplasms - radiotherapy; Neoplasm Proteins - antagonists & inhibitors; Neoplasm Proteins - blood; Neoplasm Proteins - physiology; Neoplasm Recurrence, Local - blood; Prognosis; Radiation Tolerance; Radiotherapy; Receptors, OSM-LIF; Ribosomal Protein S6 Kinases, 70-kDa - physiology; Signal Transduction - physiology; Sirolimus - pharmacology; TOR Serine-Threonine Kinases - physiology; Tumor Cells, Cultured; Tumor Microenvironment; Tumors; Viral Matrix Proteins - physiology; Taiwan